HomeLLY • NYSE
add
Eli Lilly And Co
Previous close
$896.53
Day range
$883.64 - $915.22
Year range
$623.78 - $935.63
Market cap
857.33B USD
Avg Volume
3.58M
P/E ratio
44.35
Dividend yield
0.66%
Primary exchange
NYSE
Eli Lilly's Netherlands manufacturing site
Q3 earnings report for Eli Lilly and Company
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 17.60B | 53.87% |
Operating expense | 6.09B | 29.12% |
Net income | 5.58B | 475.34% |
Net profit margin | 31.72 | 274.06% |
Earnings per share | 7.02 | 494.92% |
EBITDA | 8.97B | 78.81% |
Effective tax rate | 22.81% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.91B | 181.76% |
Total assets | 114.94B | 52.02% |
Total liabilities | 91.08B | 48.62% |
Total equity | 23.85B | — |
Shares outstanding | 895.38M | — |
Price to book | 33.75 | — |
Return on assets | 19.69% | — |
Return on capital | 34.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 5.58B | 475.34% |
Cash from operations | 8.84B | 138.04% |
Cash from investing | -2.98B | 25.52% |
Cash from financing | 531.00M | 151.30% |
Net change in cash | 6.42B | 4,312.65% |
Free cash flow | 2.22B | 256.60% |
About
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 11th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. Wikipedia
Founded
1876
Headquarters
Website
Employees
47,000
